Elocon Related Published Studies
Well-designed clinical trials related to Elocon (Mometasone Furoate Topical)
Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma. [2011.10]
Dysphagia and quality of life may improve with mometasone treatment in patients with eosinophilic esophagitis: a pilot study. [2011.10]
Application of mometasone spray to reduce sore throat after tracheal intubation. [2011.08]
The efficacy and tolerability of inhaled montelukast plus inhaled mometasone compared with mometasone alone in patients with chronic asthma. [2011.06]
Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. [2011.04.01]
Efficacy and safety of mometasone furoate nasal spray in the treatment of chronic rhinosinusitis. [2011.03]
Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. [2011.03]
Mometasone furoate effect on acute skin toxicity in breast cancer patients
receiving radiotherapy: a phase III double-blind, randomized trial from the North
Central Cancer Treatment Group N06C4. [2011]
Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma. [2010.12]
Mometasone furoate nasal spray provides early, continuing relief of nasal congestion and improves nasal patency in allergic patients. [2010.11]
Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep. [2010.07]
Efficacy and safety of two dry-powder inhalers for the administration of mometasone furoate in asthma patients. [2010.07]
Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis. [2010.06]
Daily versus self-adjusted dosing of topical mometasone furoate nasal spray in patients with allergic rhinitis: randomised, controlled trial. [2010.04]
Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study. [2010.01.05]
Effect of therapeutic doses of mometasone furoate on cortisol levels in children with mild asthma. [2010.01]
Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis. [2010.01]
Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10
microg and 400/10 microg combination treatments in patients with persistent
asthma previously receiving high-dose inhaled corticosteroids. [2010]
Comparison of patient preference for sensory attributes of fluticasone furoate or
fluticasone propionate in adults with seasonal allergic rhinitis: a randomized,
placebo-controlled, double-blind study. [2010]
Use of mometasone furoate administered via a dry powder inhaler in the treatment
of asthma. [2010]
Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray. [2009.10]
Once-Daily Evening Dosing of Mometasone Furoate Administered Via a Dry Powder Inhaler Does Not Adversely Affect the Hypothalamic-Pituitary-Adrenal Axis. [2009.09.14]
Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris. [2009.08]
Effect of the inhaled corticosteroid mometasone on small airway patency in patients with asthma. [2009.05]
Mometasone furoate nasal spray is safe and effective for 1-year treatment of children with perennial allergic rhinitis. [2009.05]
Use of mometasone furoate to prevent polyp relapse after endoscopic sinus surgery. [2009.03]
One-year treatment with mometasone furoate in chronic obstructive pulmonary disease. [2008.11.13]
Intranasal Mometasone Furoate Alleviates the Ocular Symptoms Associated with Seasonal Allergic Rhinitis: Results of a Post Hoc Analysis. [2008.07.12]
Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial. [2008.04]
Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis. [2008.04]
Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate. [2008.03]
Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. [2008.03]
Intranasal mometasone furoate alleviates the ocular symptoms associated with seasonal allergic rhinitis: results of a post hoc analysis. [2008]
Phimotic ring topical corticoid cream (0.1% mometasone furoate) treatment in children. [2007.10]
Effect of mometasone furoate nasal spray on quality of life of patients with acute rhinosinusitis. [2007.09]
The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. [2007.06]
The Role of Mometasone Furoate Aqueous Nasal Spray in the Treatment of Adenoidal Hypertrophy in the Pediatric Age Group: Preliminary Results of a Prospective, Randomized Study. [2007.05.28]
Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. [2007.03]
Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma. [2006.11]
The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. [2006.06]
Efficacy and safety of mometasone furoate vs nedocromil sodium as prophylactic treatment for moderate/severe seasonal allergic rhinitis. [2006.05]
Once-daily evening administration of mometasone furoate in asthma treatment initiation. [2006.04]
A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. [2006.02]
Decongestant effects of nasal xylometazoline and mometasone furoate in persistent allergic rhinitis. [2005.12]
Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. [2005.12]
Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. [2005.12]
Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis. [2005.12]
Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma. [2005.12]
Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis. [2005.09]
Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids. [2005.08]
Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects. [2005.07]
Comparative potency of formulations of mometasone furoate in terms of inhibition of 'PIRHR' in the forearm skin of normal human subjects measured with laser doppler velocimetry. [2005.05]
Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. [2005.03]
A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis. [2005]
Well-designed clinical trials possibly related to Elocon (Mometasone Furoate Topical)
Antibiotics for preventing meningococcal infections. [2013]
Advance II: a prospective, randomized study assessing safety and efficacy of
bioabsorbable steroid-releasing sinus implants. [2012]
In vivo vitiligo induction and therapy model: double-blind, randomized clinical
trial. [2012]
Effect of antioxidants on the clinical outcome of patients with nasal polyposis. [2011.08]
Validation of the AQLQ12+ among adolescents and adults with persistent asthma. [2011.08]
Intranasal steroids or radiofrequency turbinoplasty in persistent allergic rhinitis: effects on quality of life and objective parameters. [2011.06]
[Evaluation of the medical and surgical treatment of pediatric chronic rhinosinusitis]. [2011.03]
Recruitment factors which affect the outcome of a seasonal allergic rhinitis trial. [2011.01]
Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent. [2011]
Adjuvant role of a new emollient cream in patients with palmar and/or plantar psoriasis: a pilot randomized open-label study. [2010.12]
Preoperative treatment with topical corticoids and bleeding during primary endoscopic sinus surgery. [2010.10]
Cost-utility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial. [2010.08]
Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. [2010.07]
Mapping analyses to estimate health utilities based on responses to the OM8-30 Otitis Media Questionnaire. [2010.02]
Evaluation of topical steroids in the treatment of superficial hemangioma. [2010.01]
To treat snoring with nasal steroids - effects on more than one level? [2010]
Olfactory cleft inflammation is present in seasonal allergic rhinitis and is
reduced with intranasal steroids. [2010]
Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care: double blind randomised placebo controlled trial. [2009.12.16]
Intranasal steroids for acute sinusitis. [2009.10.07]
Effect of corticosteroids on wound healing after endoscopic sinus surgery. [2009.09]
Comparative adrenocortical suppression in dogs with otitis externa following topical otic administration of four different glucocorticoid-containing medications. [2008.06]
Effect of nasal steroid treatment on airway inflammation determined by exhaled nitric oxide in allergic schoolchildren with perennial rhinitis and asthma. [2008.05]
[Patient preference survey on the lack of taste and odor of Nasonex nasal spray. Which impact on compliance to treatment?] [2008]
Steroids for acute sinusitis. [2007.04.18]
Is the usage of intranasal glucocorticosteroids alone in allergic rhinitis sufficient? [2006.05]
The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. [2006.04]
[Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone] [2005.05]
Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis. [2005.05]
Hydrocortisone butyrate 0.1% cream in the treatment of chronic dermatitis. [2005.02]
Development of questionnaires to measure patient preferences for intranasal corticosteroids in patients with allergic rhinitis. [2005.02]
Other research related to Elocon (Mometasone Furoate Topical)
A patient preference and satisfaction study of ciclesonide nasal aerosol and
mometasone furoate aqueous nasal spray in patients with perennial allergic
rhinitis. [2013]
The effects of mometasone furoate and desloratadine in obstructive sleep apnea
syndrome patients with allergic rhinitis. [2013]
Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate
(Flixonase) nasal sprays in the treatment of dust mite-sensitive children with
perennial allergic rhinitis. [2013]
The role of mometasone furoate nasal spray in the treatment of adenoidal
hypertrophy in the adolescents: a prospective, randomized, cross-over study. [2013]
Vandetanib: in medullary thyroid cancer. [2012]
Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life,
rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial
allergic rhinitis. [2012]
Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand
eczema: a prospective randomized clinical study. [2012]
Comparison of montelukast and mometasone furoate in the prevention of recurrent
nasal polyps. [2012]
Mometasone furoate/formoterol in the treatment of persistent asthma. [2011.12]
Powered-assisted partial turbinectomy versus mometasone furoate nasal spray for relief of nasal blockage in chronic or idiopathic rhinosinusitis. [2011.12]
Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function. [2011.08.04]
Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination. [2011.08]
Application of mometasone spray to reduce sore throat after tracheal intubation. [2011]
Mometasone furoate nasal spray for moderate-to-severe nasal congestion in
subjects with seasonal allergic rhinitis. [2011]
Comparison of high-dose salmeterol/fluticasone and moderate-dose
salmeterol/fluticasone plus low-dose mometasone in patients with severe
persistent asthma. [2011]
Impact of mometasone furoate nasal spray on individual ocular symptoms of
allergic rhinitis: a meta-analysis. [2011]
Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma. [2010.09.28]
|